Analisis Keuangan Saham TNDM - Tandem Diabetes Care, Inc. (BMV) Stock

Tandem Diabetes Care, Inc.
MX ˙ BMV ˙ US8753722037
Gambaran Umum
Tandem Diabetes Care, Inc., based in the United States, operates primarily within the healthcare sector, specializing in the design, development, and commercialization of products for people with insulin-dependent diabetes. The company's innovative portfolio focuses primarily on insulin pump technology and includes the t:slim X2 insulin pump, which is notable for its user-friendly touch screen interface. Tandem Diabetes Care is also committed to advancing diabetes management technology through continuous development of their integrated diabetes management solutions. These efforts include the integration of their pumps with continuous glucose monitoring systems to enhance therapy effectiveness and user convenience, thereby supporting better glycemic control for its users. This focus on high-tech, user-centric design keeps Tandem at the forefront of the medical device industry in diabetes care.
Skor Kualitas, Nilai, dan Momentum

Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.

Kualitas

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Nilai

Model penilaian eksklusif yang memberi peringkat pada perusahaan berdasarkan valuasi relatifnya. Skor berkisar antara 0 hingga 100, dengan 100 sebagai yang paling diremehkan nilainya.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Sentimen Dana

Skor Sentimen Dana (sebelumnya dikenal sebagai Skor Kepemilikan) adalah model kuantitatif eksklusif yang memberi peringkat pada perusahaan berdasarkan tingkat akumulasi kepemilikan.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
  • Nilai revenue untuk Tandem Diabetes Care, Inc. per 2025 Jun 30 adalah 1,001.72 MM.
  • Nilai operating income untuk Tandem Diabetes Care, Inc. per 2025 Jun 30 adalah -93.03 MM.
  • Nilai net income untuk Tandem Diabetes Care, Inc. per 2025 Jun 30 adalah -205.45 MM.
Period End (TTM) Revenue (MM) Operating Income (MM) Net Income (MM)
2025-06-30 1,001.72 -93.03 -205.45
2025-03-31 982.95 -91.94 -183.87
2024-12-31 940.20 -99.13 -96.03
2024-09-30 854.35 -133.00 -126.78
2024-06-30 796.00 -139.06 -136.49
2024-03-31 770.01 -132.99 -141.45
2023-12-31 747.72 -140.38 -222.61
2023-09-30 771.42 -108.58 -208.46
2023-06-30 790.35 -95.61 -224.47
2023-03-31 794.69 -83.14 -203.75
2022-12-31 801.22 -61.81 -94.59
2022-09-30 790.71 -31.32 -67.93
2022-06-30 765.79 -7.12 -13.17
2022-03-31 737.67 10.55 5.89
2021-12-31 702.80 22.65 15.57
2021-09-30 660.87 28.58 21.76
2021-06-30 604.84 19.85 6.56
2021-03-31 541.94 2.38 -24.56
2020-12-31 498.83 -7.96 -34.38
2020-09-30 439.16 -24.48 -48.73
2020-06-30
2020-03-31
Laporan Laba Rugi: EPS
Period End (TTM) Earnings Per Share Basic Earnings Per Share Diluted
2025-06-30
2025-03-31
2024-12-31 -1.47
2024-09-30 -1.94 -1.94
2024-06-30 -2.09 -2.10
2024-03-31 -2.17 -2.17
2023-12-31 -3.43
2023-09-30 -3.22 -3.22
2023-06-30 -3.48 -3.47
2023-03-31 -3.17 -3.16
2022-12-31 -1.47
2022-09-30 -1.06 -1.06
2022-06-30 -0.21 -0.21
2022-03-31 0.09 0.09
2021-12-31 0.25 0.24
2021-09-30 0.35 0.34
2021-06-30 0.11 0.11
2021-03-31 -0.40 -0.39
2020-12-31 -0.56 -0.56
2020-09-30 -0.81 -0.81
2020-06-30 -0.71 -0.71
2020-03-31 -0.28 -0.28
Arus Kas: Operasi, Investasi, Pendanaan
  • Nilai cash from operating activities untuk Tandem Diabetes Care, Inc. per 2025 Jun 30 adalah 9.72 MM.
  • Nilai cash from investing activities untuk Tandem Diabetes Care, Inc. per 2025 Jun 30 adalah 52.43 MM.
  • Nilai kas dari aktivitas pendanaan untuk Tandem Diabetes Care, Inc. per 2025 Jun 30 adalah -46.62 MM.
Period End (TTM) Cash From Operating Activities (MM) Cash From Investing Activities (MM) Cash From Financing Activities (MM)
2025-06-30 9.72 52.43 -46.62
2025-03-31 13.94 -9.24 -9.91
2024-12-31 24.23 -23.48 8.37
2024-09-30 6.29 -45.08 8.68
2024-06-30 -20.43 -73.70 11.29
2024-03-31 -21.48 -64.47 18.24
2023-12-31 -31.81 -85.74 4.11
2023-09-30 -18.77 -33.38 7.60
2023-06-30 5.11 0.98 8.73
2023-03-31 18.34 1.64 12.84
2022-12-31 50.46 33.17 16.88
2022-09-30 64.28 -79.43 26.66
2022-06-30 74.48 -104.47 46.29
2022-03-31 96.47 -175.59 51.86
2021-12-31 111.36 -186.88 51.93
2021-09-30 106.96 -169.68 45.25
2021-06-30 87.38 -268.31 56.33
2021-03-31 73.98 -335.07 306.53
2020-12-31 24.67 -296.06 314.44
2020-09-30 28.88 -257.33 311.65
2020-06-30
2020-03-31
Metrik Penilaian: PE, PriceToBook, PriceToTBV
P/Book
The current closing price divided by the book value per share.
P/TBV
The current price divided by the tangible book value per share.
Period End (TTM) p/e P/Book P/TBV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) EBIT/EV EBIT (3y)/EV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
Efektivitas Manajemen
  • roe untuk Tandem Diabetes Care, Inc. pada 2025 Jun 30 adalah -0.18.
Period End (TTM) ROA ROE ROIC (Tingkat Pengembalian Investasi Modal) CROIC OCROIC
2025-06-30 -0.18
2025-03-31 -0.18
2024-12-31 -0.18
2024-09-30 -0.18
2024-06-30 -0.18
2024-03-31 -0.18
2023-12-31 -0.18
2023-09-30 -0.18
2023-06-30 -0.18
2023-03-31 -0.18
2022-12-31 -0.18
2022-09-30 -0.18
2022-06-30 -0.18
2022-03-31 -0.18
2021-12-31 -0.18
2021-09-30 -0.18
2021-06-30 -0.18
2021-03-31 -0.18
2020-12-31 -0.11 -0.18 -0.06 0.07 0.04
2020-09-30 -0.17 -0.29 -0.09 0.15 0.05
2020-06-30 -0.17 -0.29 -0.09 0.38 0.08
2020-03-31 -0.08 -0.14 -0.07 0.14 0.11
Gross Margins
  • marjin kotor untuk Tandem Diabetes Care, Inc. pada 2025 Jun 30 adalah 0.52.
  • marjin bersih untuk Tandem Diabetes Care, Inc. pada 2025 Jun 30 adalah -0.07.
  • marjin operasi untuk Tandem Diabetes Care, Inc. pada 2025 Jun 30 adalah -0.02.
Margin Kotor
The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
Margin Keuntungan Bersih
Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
Margin Operasi
Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) Margin Kotor Margin Keuntungan Bersih Margin Operasi
2025-06-30 0.52 -0.07 -0.02
2025-03-31 0.52 -0.07 -0.02
2024-12-31 0.52 -0.07 -0.02
2024-09-30 0.52 -0.07 -0.02
2024-06-30 0.52 -0.07 -0.02
2024-03-31 0.52 -0.07 -0.02
2023-12-31 0.52 -0.07 -0.02
2023-09-30 0.52 -0.07 -0.02
2023-06-30 0.52 -0.07 -0.02
2023-03-31 0.52 -0.07 -0.02
2022-12-31 0.52 -0.07 -0.02
2022-09-30 0.52 -0.07 -0.02
2022-06-30 0.52 -0.07 -0.02
2022-03-31 0.52 -0.07 -0.02
2021-12-31 0.52 -0.07 -0.02
2021-09-30 0.52 -0.07 -0.02
2021-06-30 0.52 -0.07 -0.02
2021-03-31 0.52 -0.07 -0.02
2020-12-31 0.52 -0.07 -0.02
2020-09-30 0.52 -0.11 -0.06
2020-06-30 0.53 -0.10 -0.07
2020-03-31 0.54 -0.04 -0.05
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK)1438133
Other Listings
DE:TD5A € 10.52
GB:0M0F
US:TNDM US$ 12.58
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista